Proapoptotic regimes for HTLV-I-transformed cells: Targeting Tax and the NF-κB pathway

Kfoury Y.; Nasr R.; Hermine O.; de The H.; Bazarbachi A.

AUB ScholarWorks Home
→
Faculty of Medicine (FM)
→
Internal Medicine - Faculty Publications
→
View Item

dc.contributor.author	Kfoury Y.
dc.contributor.author	Nasr R.
dc.contributor.author	Hermine O.
dc.contributor.author	de The H.
dc.contributor.author	Bazarbachi A.
dc.contributor.editor
dc.date	5-Aug
dc.date.accessioned	2017-10-05T15:37:15Z
dc.date.available	2017-10-05T15:37:15Z
dc.date.issued	2005
dc.identifier	10.1038/sj.cdd.4401624
dc.identifier.issn	13509047
dc.identifier.uri	http://hdl.handle.net/10938/15578
dc.description.abstract	[No abstract available]
dc.format.extent	Pages: (871-877)
dc.language	English
dc.publisher	LONDON
dc.relation.ispartof	Publication Name: Cell Death and Differentiation; Publication Year: 2005; Volume: 12; suppl. 1; Pages: (871-877);
dc.source	Scopus
dc.title	Proapoptotic regimes for HTLV-I-transformed cells: Targeting Tax and the NF-κB pathway
dc.type	Review
dc.contributor.affiliation	Kfoury, Y., Department of Internal Medicine, American University of Beirut, PO Box 113-6044, Beirut, Lebanon
dc.contributor.affiliation	Nasr, R., Department of Internal Medicine, American University of Beirut, PO Box 113-6044, Beirut, Lebanon
dc.contributor.affiliation	Hermine, O., CNRS UMR 8603, Department of Hematology, Necker Hospital, Paris, France
dc.contributor.affiliation	de Thé, H., UPR 9051 CNRS, Laboratoire Associé au Comité de Paris de la Ligue contre le Cancer, Hopital St. Louis, 1 Av. C. Vellefaux, 75475 Paris Cedex 10, France
dc.contributor.affiliation	Bazarbachi, A., Department of Internal Medicine, American University of Beirut, PO Box 113-6044, Beirut, Lebanon
dc.contributor.authorAddress	Bazarbachi, A.; Department of Internal Medicine, American University of Beirut, 1 Av. C. Vellefaux, Beirut, Lebanon; email: bazarbac@aub.edu.lb
dc.contributor.authorCorporate	University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment	Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail	dethe@chu-stlouis.fr
dc.contributor.faculty	Faculty of Medicine
dc.contributor.authorInitials	Kfoury, Y
dc.contributor.authorInitials	Nasr, R
dc.contributor.authorInitials	Hermine, O
dc.contributor.authorInitials	de The, H
dc.contributor.authorInitials	Bazarbachi, A
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress	Bazarbachi, A (reprint author), Amer Univ Beirut, Dept Internal Med, POB 113-6044, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity	American University of Beirut Medical Center
dc.description.cited	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016-S0305-7372(03)00081-1; Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182-blood-2001-12-0372; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146-annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146-annurev.immunol.14.1.649; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126-science.2843985; Bangham CRM, 2000, CURR OPIN IMMUNOL, V12, P397, DOI 10.1016-S0952-7915(00)00107-2; Bazarbachi A, 1999, BLOOD, V93, P278; Bazarbachi A, 2001, VIRUS RES, V78, P79, DOI 10.1016-S0168-1702(01)00286-6; Bazarbachi A, 2004, CANCER RES, V64, P2039, DOI 10.1158-0008-5472.CAN-03-2390; Bazarbachi A, 2004, LANCET ONCOL, V5, P664, DOI 10.1016-S1470-2045(04)01608-0; BERAUD C, 1996, J ACQ IMMUN DEF SYND, V13, P76; Bex F, 1998, MOL CELL BIOL, V18, P2392; Bex F, 1997, J VIROL, V71, P3484; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084-jem.179.3.901; Brauweiler A, 1997, VIROLOGY, V231, P135, DOI 10.1006-viro.1997.8509; Burton M, 2000, J VIROL, V74, P2351, DOI 10.1128-JVI.74.5.2351-2364.2000; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093-emboj-21.11.2636; Chen GQ, 1996, BLOOD, V88, P1052; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016-S0092-8674(00)81064-8; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128-JVI.78.21.11823-11832.2004; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074-jbc.273.26.15891; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016-j.tcb.2004.01.004; Dewan MZ, 2003, J VIROL, V77, P5286, DOI 10.1128-JVI.77.9.5286-5294.2003; El-Sabban ME, 2002, BLOOD, V99, P3383, DOI 10.1182-blood.V99.9.3383; El-Sabban ME, 2000, BLOOD, V96, P2849; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074-jbc.M210631200; Gabet AS, 2003, ONCOGENE, V22, P3734, DOI 10.1038-sj.onc.1206468; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 1996, ADV VIRUS RES, V47, P377, DOI 10.1016-S0065-3527(08)60740-X; Good LF, 1996, J VIROL, V70, P2730; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3351, DOI 10.1073-pnas.86.9.3351; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074-jbc.273.39.25185; Hemelaar J, 2001, J VIROL, V75, P11106, DOI 10.1128-JVI.75.22.11106-11115.2001; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016-0092-8674(92)90083-O; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038-sj.thj.6200374; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146-annurev.biochem.67.1.425; HINUMA Y, 1982, GAN TO KAGAKU RYOHO, V8, P1313; HIRAI H, 1994, P NATL ACAD SCI USA, V91, P3584, DOI 10.1073-pnas.91.9.3584; HIRAI H, 1992, ONCOGENE, V7, P1737; Huang GJ, 2002, FEBS LETT, V531, P494, DOI 10.1016-S0014-5793(02)03590-1; Ikeda K, 1999, INT J CANCER, V82, P599, DOI 10.1002-(SICI)1097-0215(19990812)82:4599
dc.description.citedCount	23
dc.description.citedTotWOSCount	22
dc.description.citedWOSCount	20
dc.format.extentCount	7
dc.identifier.coden	CDDIE
dc.identifier.pubmedID	15846376
dc.identifier.scopusID	22744454818
dc.publisher.address	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
dc.relation.ispartOfISOAbbr	Cell Death Differ.
dc.relation.ispartofPubTitle	Cell Death and Differentiation
dc.relation.ispartofPubTitleAbbr	Cell Death Differ.
dc.relation.ispartOfSuppl	1
dc.relation.ispartOfVolume	12
dc.source.ID	WOS:000230508800006
dc.type.publication	Journal
dc.subject.otherChemCAS	arsenic trioxide, 1303-24-8, 1327-53-3, 13464-58-9, 15502-74-6
dc.subject.otherChemCAS	bortezomib, 179324-69-7, 197730-97-5
dc.subject.otherChemCAS	doxorubicin, 23214-92-8, 25316-40-9
dc.subject.otherChemCAS	etoposide, 33419-42-0
dc.subject.otherChemCAS	interleukin 2 receptor antibody, 179045-86-4
dc.subject.otherChemCAS	retinoic acid, 302-79-4
dc.subject.otherChemCAS	zidovudine, 30516-87-1
dc.subject.otherChemCAS	3-(4-methylphenylsulfonyl)-2-propenenitrile
dc.subject.otherChemCAS	Antineoplastic Agents
dc.subject.otherChemCAS	arsenic trioxide, 1327-53-3
dc.subject.otherChemCAS	Arsenicals
dc.subject.otherChemCAS	Gene Products, tax
dc.subject.otherChemCAS	NF-kappa B
dc.subject.otherChemCAS	Nitriles
dc.subject.otherChemCAS	Oxides
dc.subject.otherChemCAS	Proteasome Endopeptidase Complex, EC 3.4.25.1
dc.subject.otherChemCAS	Sulfones
dc.subject.otherIndex	3 (4 methylphenylsulfonyl) 2 propenenitrile
dc.subject.otherIndex	alpha interferon
dc.subject.otherIndex	antineoplastic agent
dc.subject.otherIndex	arsenic trioxide
dc.subject.otherIndex	bortezomib
dc.subject.otherIndex	doxorubicin
dc.subject.otherIndex	etoposide
dc.subject.otherIndex	immunoglobulin enhancer binding protein
dc.subject.otherIndex	interleukin 2 receptor antibody
dc.subject.otherIndex	proteasome inhibitor
dc.subject.otherIndex	retinoic acid
dc.subject.otherIndex	Tax protein
dc.subject.otherIndex	zidovudine
dc.subject.otherIndex	antineoplastic activity
dc.subject.otherIndex	antiviral activity
dc.subject.otherIndex	apoptosis
dc.subject.otherIndex	cancer inhibition
dc.subject.otherIndex	cancer resistance
dc.subject.otherIndex	cell cycle
dc.subject.otherIndex	clinical trial
dc.subject.otherIndex	dose response
dc.subject.otherIndex	drug efficacy
dc.subject.otherIndex	drug megadose
dc.subject.otherIndex	drug potentiation
dc.subject.otherIndex	drug response
dc.subject.otherIndex	drug specificity
dc.subject.otherIndex	drug targeting
dc.subject.otherIndex	human
dc.subject.otherIndex	Human T cell leukemia virus 1
dc.subject.otherIndex	nonhuman
dc.subject.otherIndex	priority journal
dc.subject.otherIndex	prognosis
dc.subject.otherIndex	protein function
dc.subject.otherIndex	review
dc.subject.otherIndex	sexual transmission
dc.subject.otherIndex	spastic paraplegia
dc.subject.otherIndex	T cell leukemia
dc.subject.otherIndex	T cell lymphoma
dc.subject.otherIndex	vertical transmission
dc.subject.otherIndex	virus carcinogenesis
dc.subject.otherIndex	virus cell transformation
dc.subject.otherIndex	virus gene
dc.subject.otherIndex	virus pathogenesis
dc.subject.otherIndex	virus transmission
dc.subject.otherIndex	Animals
dc.subject.otherIndex	Antineoplastic Agents
dc.subject.otherIndex	Apoptosis
dc.subject.otherIndex	Arsenicals
dc.subject.otherIndex	Drug Delivery Systems
dc.subject.otherIndex	Gene Expression Regulation
dc.subject.otherIndex	Gene Products, tax
dc.subject.otherIndex	Human T-lymphotropic virus 1
dc.subject.otherIndex	Humans
dc.subject.otherIndex	Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated
dc.subject.otherIndex	NF-kappa B
dc.subject.otherIndex	Nitriles
dc.subject.otherIndex	Oxides
dc.subject.otherIndex	Proteasome Endopeptidase Complex
dc.subject.otherIndex	Sulfones
dc.subject.otherIndex	T-Lymphocytes
dc.subject.otherIndex	HTLV
dc.subject.otherIndex	Human T-lymphotropic virus 1
dc.subject.otherKeywordPlus	VIRUS TYPE-I
dc.subject.otherKeywordPlus	PROTEASOME INHIBITOR PS-341
dc.subject.otherKeywordPlus	HUMAN T-CELLS
dc.subject.otherKeywordPlus	TYPE-1 TAX
dc.subject.otherKeywordPlus	ARSENIC TRIOXIDE
dc.subject.otherKeywordPlus	LEUKEMIA-CELLS
dc.subject.otherKeywordPlus	TRANSCRIPTIONAL ACTIVATION
dc.subject.otherKeywordPlus	NUCLEAR TRANSLOCATION
dc.subject.otherKeywordPlus	ONCOPROTEIN TAX
dc.subject.otherKeywordPlus	DOWN-REGULATION
dc.subject.otherWOS	Biochemistry and Molecular Biology
dc.subject.otherWOS	Cell Biology

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Internal Medicine - Faculty Publications [971]

Show simple item record

Search AUB ScholarWorks

Browse

All of AUB ScholarWorks
This Collection
- By Issue Date
- Authors
- Titles
- Subjects

My Account

Copyright Statement

All materials included in the institutional repository are protected by copyright laws and are the property of their respective copyright holders. Materials may be used for non-commercial, educational, or research purposes only, and must be cited or attributed to the original source. Permission for any other use must be obtained from the copyright holder(s) directly. The American University of Beirut Libraries does not assume responsibility for any infringement of copyright laws that may occur as a result of the use of materials in the repository. If you believe that your copyright has been infringed upon in the repository, please contact the AUB Libraries immediately.

For further information, please contact us at scholarworks@aub.edu.lb